Abstract
A SNP in the gene PTPN22 is associated with type 1 diabetes, rheumatoid arthritis, lupus, Graves thyroiditis, Addison disease and other autoimmune disorders. T cells from carriers of the predisposing allele produce less interleukin-2 upon TCR stimulation, and the encoded phosphatase has higher catalytic activity and is a more potent negative regulator of T lymphocyte activation. We conclude that the autoimmune-predisposing allele is a gain-of-function mutant.
MeSH Terms
Alleles
Antibodies/pharmacology
Autoimmune Diseases/enzymology,genetics,immunology
Catalysis
Diabetes Mellitus, Type 1/enzymology,genetics,immunology
Female
Gene Frequency
Genetic Predisposition to Disease
Heterozygote
Humans
Interleukin-2/metabolism
Italy
Lymphocyte Activation
Male
Mutation
Polymorphism, Single Nucleotide
Protein Tyrosine Phosphatase, Non-Receptor Type 1
Protein Tyrosine Phosphatase, Non-Receptor Type 22
Protein Tyrosine Phosphatases/genetics
Receptors, Antigen, T-Cell/drug effects,metabolism
T-Lymphocytes/enzymology,immunology
Chemicals
Antibodies
Interleukin-2
Receptors, Antigen, T-Cell
PTPN22 protein, human
Protein Tyrosine Phosphatase, Non-Receptor Type 1
Protein Tyrosine Phosphatase, Non-Receptor Type 22
Protein Tyrosine Phosphatases
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Vang Torkel
Program on Inflammatory Disease Research, Infectious and Inflammatory Disease Center, The Burnham Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, USA.
Congia Mauro
Macis Maria Doloretta
Musumeci Lucia
Orrú Valeria
Zavattari Patrizia
Nika Konstantina
Tautz Lutz
Taskén Kjetil
Cucca Francesco
Mustelin Tomas
Bottini Nunzio